TG Therapeutics Inc TGTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:23 PM EDT
36.84quote price arrow up+0.23 (+0.63%)
Volume
14,257
Close
36.61quote price arrow up+2.52 (+7.39%)
Volume
663,504
52 week range
17.67 - 56.74

...

Loading . . .
  • Open34.53
  • Day High36.80
  • Day Low34.39
  • Prev Close34.09
  • 52 Week High56.74
  • 52 Week High Date01/13/21
  • 52 Week Low17.67
  • 52 Week Low Date08/12/20

Key Stats

  • Market Cap5.201B
  • Shares Out142.07M
  • 10 Day Average Volume0.78M
  • Dividend-
  • Dividend Yield-
  • Beta2.13
  • YTD % Change-29.62

KEY STATS

  • Open34.53
  • Day High36.80
  • Day Low34.39
  • Prev Close34.09
  • 52 Week High56.74
  • 52 Week High Date01/13/21
  • 52 Week Low17.67
  • 52 Week Low Date08/12/20
  • Market Cap5.201B
  • Shares Out142.07M
  • 10 Day Average Volume0.78M
  • Dividend-
  • Dividend Yield-
  • Beta2.13
  • YTD % Change-29.62

RATIOS/PROFITABILITY

  • EPS (TTM)-2.60
  • P/E (TTM)-14.07
  • Fwd P/E (NTM)-21.15
  • EBITDA (MRQ)-312.364M
  • ROE (MRQ)-143.67%
  • Revenue (MRQ)910,000.00
  • Gross Margin (MRQ)72.11%
  • Net Margin (MRQ)-35,159.10%
  • Debt To Equity (MRQ)6.96%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On TG Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
TG Therapeutics, Inc. (TG) is a biopharmaceutical company focused on the acquisition, development and commercialization of treatments for B-cell malignancies and autoimmune diseases. As of December 31, 2016, the Company was developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a glycoengineered monoclonal antibody that targets a specific epitope on the cluster of differentiation (CD20) antigen found on mature B-lymphocytes. The Company is...
Michael Weiss J.D.
Chairman
Sean Power CPA
Chief Financial Officer
Address
2 Gansevoort St Fl 9
New York, NY
10014-1667
United States

Top Peers

SYMBOLLASTCHG%CHG
BEAM
Beam Therapeutics Inc
88.61+4.24+5.03%
EIDX
SAVA
Cassava Sciences Inc
135.30+7.80+6.12%
RETA
Reata Pharmaceuticals Inc
128.67+4.45+3.58%
ARVN
Arvinas Inc
103.85+9.80+10.42%